tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline (GSK) Ratios

Compare
4,989 Followers

GlaxoSmithKline Ratios

GSK's free cash flow for Q1 2025 was £0.74. For the 2025 fiscal year, GSK's free cash flow was decreased by £ and operating cash flow was £0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.91 0.88 0.91 0.79 0.91
Quick Ratio
0.68 0.62 0.68 0.54 0.64
Cash Ratio
0.16 0.13 0.16 0.18 0.28
Solvency Ratio
0.14 0.16 0.14 0.11 0.14
Operating Cash Flow Ratio
0.32 0.32 0.32 0.34 0.38
Short-Term Operating Cash Flow Coverage
1.96 2.55 1.96 2.34 2.41
Net Current Asset Value
£ -29.28B£ -27.57B£ -29.28B£ -39.09B£ -39.38B
Leverage Ratios
Debt-to-Assets Ratio
0.35 0.31 0.35 0.31 0.34
Debt-to-Equity Ratio
1.98 1.35 1.98 1.61 1.86
Debt-to-Capital Ratio
0.66 0.57 0.66 0.62 0.65
Long-Term Debt-to-Capital Ratio
0.60 0.51 0.60 0.57 0.61
Financial Leverage Ratio
5.68 4.42 5.68 5.25 5.51
Debt Service Coverage Ratio
1.70 2.44 1.70 1.77 2.18
Interest Coverage Ratio
7.32 8.70 7.32 7.91 8.73
Debt to Market Cap
0.17 0.28 0.17 0.22 0.24
Interest Debt Per Share
5.43 4.64 5.43 7.79 7.04
Net Debt to EBITDA
2.00 1.67 2.00 2.57 2.05
Profitability Margins
Gross Profit Margin
67.42%71.76%67.42%65.99%65.68%
EBIT Margin
22.01%22.39%22.01%12.79%22.91%
EBITDA Margin
29.43%30.13%29.43%22.74%29.80%
Operating Profit Margin
21.94%22.24%21.94%18.18%22.82%
Pretax Profit Margin
19.19%19.99%19.19%15.95%20.43%
Net Profit Margin
16.78%16.25%16.78%12.85%16.86%
Continuous Operations Profit Margin
16.79%17.50%16.79%10.31%18.64%
Net Income Per EBT
87.44%81.27%87.44%80.58%82.51%
EBT Per EBIT
87.49%89.90%87.49%87.76%89.53%
Return on Assets (ROA)
8.18%8.35%8.18%5.54%7.15%
Return on Equity (ROE)
46.43%36.92%46.43%29.13%39.41%
Return on Capital Employed (ROCE)
17.23%17.78%17.23%11.19%13.35%
Return on Invested Capital (ROIC)
13.62%14.49%13.62%9.84%11.51%
Return on Tangible Assets
12.69%13.17%12.69%11.40%14.37%
Earnings Yield
4.21%8.35%4.21%4.20%5.36%
Efficiency Ratios
Receivables Turnover
5.38 5.14 5.38 5.46 6.15
Payables Turnover
2.47 2.30 2.47 2.56 2.69
Inventory Turnover
1.86 1.56 1.86 2.01 1.95
Fixed Asset Turnover
3.05 3.05 3.05 3.20 3.10
Asset Turnover
0.49 0.51 0.49 0.43 0.42
Working Capital Turnover Ratio
-8.33 -13.58 -8.33 -9.89 -10.56
Cash Conversion Cycle
116.76 146.97 116.76 106.09 110.51
Days of Sales Outstanding
67.86 71.07 67.86 66.83 59.40
Days of Inventory Outstanding
196.60 234.30 196.60 181.92 186.99
Days of Payables Outstanding
147.70 158.40 147.70 142.66 135.88
Operating Cycle
264.46 305.37 264.46 248.75 246.39
Cash Flow Ratios
Operating Cash Flow Per Share
1.84 1.67 1.84 2.48 2.12
Free Cash Flow Per Share
1.28 1.09 1.28 1.57 1.56
CapEx Per Share
0.56 0.58 0.56 0.92 0.56
Free Cash Flow to Operating Cash Flow
0.69 0.65 0.69 0.63 0.73
Dividend Paid and CapEx Coverage Ratio
1.29 1.47 1.29 1.15 1.36
Capital Expenditure Coverage Ratio
3.28 2.89 3.28 2.71 3.77
Operating Cash Flow Coverage Ratio
0.35 0.38 0.35 0.33 0.31
Operating Cash Flow to Sales Ratio
0.25 0.22 0.25 0.23 0.25
Free Cash Flow Yield
4.40%3.75%4.40%4.81%5.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.77 11.98 23.77 23.80 18.65
Price-to-Sales (P/S) Ratio
3.99 1.95 3.99 3.06 3.14
Price-to-Book (P/B) Ratio
11.04 4.42 11.04 6.93 7.35
Price-to-Free Cash Flow (P/FCF) Ratio
22.73 13.34 22.73 20.78 17.29
Price-to-Operating Cash Flow Ratio
15.80 8.72 15.80 13.12 12.70
Price-to-Earnings Growth (PEG) Ratio
-2.17 0.00 -2.17 -4.90 0.81
Price-to-Fair Value
11.04 4.42 11.04 6.93 7.35
Enterprise Value Multiple
15.55 8.13 15.55 16.02 12.60
Enterprise Value
134.22B 133.35B 134.22B 124.24B 128.08B
EV to EBITDA
15.55 14.59 15.55 16.02 12.60
EV to Sales
4.58 4.40 4.58 3.64 3.76
EV to Free Cash Flow
26.09 30.14 26.09 24.74 20.65
EV to Operating Cash Flow
18.13 19.70 18.13 15.62 15.17
Tangible Book Value Per Share
-2.80 -2.17 -2.80 -6.02 -4.93
Shareholders’ Equity Per Share
2.63 3.29 2.63 4.70 3.66
Tax and Other Ratios
Effective Tax Rate
0.13 0.12 0.13 0.06 0.08
Revenue Per Share
7.28 7.48 7.28 10.65 8.57
Net Income Per Share
1.22 1.22 1.22 1.37 1.44
Tax Burden
0.87 0.81 0.87 0.81 0.83
Interest Burden
0.87 0.89 0.87 1.25 0.89
Research & Development to Revenue
0.19 0.21 0.19 0.15 0.15
SG&A to Revenue
0.29 0.31 0.29 0.32 0.34
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.01 <0.01
Income Quality
1.50 1.37 1.50 1.56 1.32
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis